Concepedia

TJ Smilde

TS

Statistics

Publications

3

Citations

1K

H-Index

3

Active since

2001

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

TJ Smilde is an author at Radboud University Medical Center specializing in medicine, oncology, and hormone receptor - positive breast cancer.

Publications per year

2001–2017

3

Publications

3

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial

TJ Smilde, Sanne van Wissen, H Awollersheim et al. · The Lancet · 2001 · 922 citations

, , +13

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Annals of Oncology · 2015 · 81 citations · Full text

, , +16

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations · Full text

, , +17

1–3 of 3